HGH Fragment 176–191 explained

Human Growth Hormone Fragment 176–191 (hGH frag 176–191) is a peptide fragment of human growth hormone. It has erroneously been presented as a lipolytic peptide fragment based on extrapolations of clinical data pertaining to AOD9604, a modified form of hGH frag 176–191. In contrast to AOD9604, hGH frag 176–191 has not been studied in humans.^[1]

Extra reading

• Habibullah . Mahmoud M . Mohan . Syam . Syed . Nabeel Kashan . Makeen . Hafiz A . Jamal . Qazi Mohammad Sajid . Alothaid . Hani . Bantun . Farkad . Alhazmi . Alaa . Hakamy . Ali . Kaabi . Yahia A . Samlan . Ghalia . Lohani . Mohtashim . Thangavel . Neelaveni . Al-Kasim . Mohamed Ahmed . Human Growth Hormone Fragment 176–191 Peptide Enhances the Toxicity of Doxorubicin-Loaded Chitosan Nanoparticles Against MCF-7 Breast Cancer Cells . Drug Design, Development and Therapy . June 2022 . 16 . 1963–1974 . 10.2147/DDDT.S367586 . 35783198 . 9249349 . free .

Notes and References

1. Web site: Human Growth Hormone Fragment 176-191 - Search Results - PubMed . 2023-12-23 . PubMed . en.